Rosetta Genomics's total assets for Q0 0 were $6.21M, a decrease of -48.11% from the previous quarter. ROSGQ total liabilities were $5.11M for the fiscal quarter, a -32.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.